Skip to main content
11 July 2025
Last updated:
Thursday 10 July 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
A scenario for shortening drug development times
Read more
Big Pharma meets Big Data
Read more
Why the UK is building cell therapy capacity
Read more
Commentary: European IPOs produce surprises
Read more
European biotechs rise in March quarter
Read more
The case for allogeneic cell therapy
Read more
Clinical and market issues for cell-based therapies
Read more
Checkpoint inhibitors - A new horizon for cancer therapy
Read more
Will scanners be the key to translational medicine?
Read more
Why the time has come for MidPharmas
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
55
Page
56
Page
57
Page
58
Current page
59
Page
60
Page
61
Page
62
Page
63
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form